The emerging role of TROP2 as a diagnostic and prognostic biomarker in bladder tumor

By Mao Ye, B. Badehnoosh. 2026

Subfields: Oncology, Urology

Citations in the corpus

• TROP2 expression in head and neck squamous cell carcinoma: association with the tumor immune microenvironment and clinical outcome (2026, unknown): “In NSCLC, urothelial carcinoma and breast cancer, TROP2 overexpression has been associated with poor prognosis, altered immune in fi ltration patterns, including increased macrophage recruitment and immune evasion mechanisms (41 – 44).”